SEC Form 4 · accession 0002123975-26-000008
BioNTech SE · BNTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ugur Sahin
Officer — Chief Executive Officer · 10% Owner
Period of report
Sep 3, 2026
Accepted (ET)
Sep 8, 2026 · 4:10 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001776985
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Sep 3, 2026 | S | 45,000 | $102.8496 | D | 813,209 | D | |
| Ordinary Shares | Sep 4, 2026 | S | 31,500 | $103.5182 | D | 781,709 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on June 3, 2026.